Cidofovir Hydrate

西多福韦

Report date: 2025/01/16 10:06:10
NME

Base Information

Drug NameCidofovir Hydrate
Drug Alias Name西道法韦CidofovirumcidofovirVistideForvade +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus DNA polymerase inhibitors
TargetsVirus DNA polymerase
Therapy Area/IndicationsBK Polyomavirus InfectionsUterine Cervical NeoplasmsPapilloma +[12] 
Global Approved IndicationsCytomegalovirus Retinitis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1996/06/26
Country/TerritoryBelgiumCanadaUnited States +[4] 
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesGilead Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of MinnesotaGilead Sciences International LtdGilead Sciences Inc +[9] 
Active IndicationsN/A
Inactive IndicationsBK Polyomavirus InfectionsUterine Cervical NeoplasmsPapilloma +[12] 

Other Information

ATC CodeJ05AB12
Related LinksWikipediaDrugBankKEGG